Rare diseases
Investigational molecules
Locations
Back to Greece973 clinical trials in Athens, Greece across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GreeceA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
GreeceStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
GreeceA study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status
GreeceA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
GreeceA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
GreeceA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
GreeceA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
GreeceA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
GreeceStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
GreeceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
GreeceGreeceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on head and neck cancer, bladder cancer, and advanced solid tumors. Research includes innovative combination therapies and novel treatment approaches for various tumor types.
Studies evaluate new therapeutic combinations and their impact on patient survival rates.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome, lupus, and inflammatory conditions.
Focus on developing targeted therapies for chronic autoimmune conditions.
Research examining treatments for heart failure, cardiovascular disease prevention, and metabolic disorders including obesity.
Trials evaluating new therapeutic approaches for cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
